Career history of Kristin Gustafson
Former positions of Kristin Gustafson
| Companies | Position | Start | End |
|---|---|---|---|
| MIRATI THERAPEUTICS | Human Resources Officer | 2019-12-31 | 2024-01-22 |
| Chemo101, Inc. | Founder | - | - |
| INTERCEPT PHARMACEUTICALS, INC. | Human Resources Officer | - | - |
| KITE PHARMA INC | Corporate Officer/Principal | - | - |
| TURNSTONE BIOLOGICS CORP. | Human Resources Officer | - | - |
Training of Kristin Gustafson
| University of Wisconsin | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Human Resources Officer | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Private companies | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
| Chemo101, Inc. |
- Stock Market
- Insiders
- Kristin Gustafson
- Experience
